Trends in Swedish physicians' attitudes towards physician-assisted suicide: a cross-sectional study.
Autonomy principle
Non-maleficent principle
Physician assisted suicide
Physician attitude
Prescribing drugs
Trust in healthcare
Journal
BMC medical ethics
ISSN: 1472-6939
Titre abrégé: BMC Med Ethics
Pays: England
ID NLM: 101088680
Informations de publication
Date de publication:
02 07 2021
02 07 2021
Historique:
received:
30
03
2021
accepted:
16
06
2021
entrez:
3
7
2021
pubmed:
4
7
2021
medline:
7
8
2021
Statut:
epublish
Résumé
To examine attitudes towards physician-assisted suicide (PAS) among physicians in Sweden and compare these with the results from a similar cross-sectional study performed in 2007. A random selection of 250 physicians from each of six specialties (general practice, geriatrics, internal medicine, oncology, surgery and psychiatry) and all 127 palliative care physicians in Sweden were invited to participate in this study. A postal questionnaire commissioned by the Swedish Medical Society in collaboration with Karolinska Institute in Stockholm. The total response rate was 59.2%. Slightly fewer than half [47.1% (95% CI 43.7-50.5)] of the respondents from the six specialties accepted PAS, which is significantly more than accepted PAS in the 2007 study [34.9% (95% CI 31.5-38.3)]. Thirty-three percent of respondents were prepared to prescribe the needed drugs. When asked what would happen to the respondent's own trust in healthcare, a majority [67.1% (95% CI 63.9-70.3)] stated that legalizing PAS would either not influence their own trust in healthcare, or that their trust would increase. This number is an increase compared to the 2007 survey, when just over half [51.9% (95% CI 48.0-55.2)] indicated that their own trust would either not be influenced, or would increase. The study reveals a shift towards a more accepting attitude concerning PAS among physicians in Sweden. Only a minority of the respondents stated that they were against PAS, and a considerable proportion reported being prepared to prescribe the needed drugs for patient self-administration if PAS were legalized.
Identifiants
pubmed: 34215231
doi: 10.1186/s12910-021-00652-0
pii: 10.1186/s12910-021-00652-0
pmc: PMC8252981
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
86Références
Tidsskr Nor Laegeforen. 2019 Jan 14;139(1):
pubmed: 30644675
J Med Ethics. 2014 May;40(5):306-9
pubmed: 23427218
Scand J Public Health. 2008 Sep;36(7):720-7
pubmed: 18775835
Yale J Biol Med. 2019 Dec 20;92(4):747-750
pubmed: 31866790
BMJ Support Palliat Care. 2015 Jun;5(2):122-3
pubmed: 25987430
Palliat Med. 2016 Feb;30(2):104-16
pubmed: 26586603
Yale J Biol Med. 2019 Dec 20;92(4):575-585
pubmed: 31866773
Ann Palliat Med. 2021 Mar;10(3):3540-3553
pubmed: 32921084
JAMA. 2016 Jul 5;316(1):79-90
pubmed: 27380345
PLoS One. 2016 Jun 23;11(6):e0158188
pubmed: 27337064
BMC Med Ethics. 2016 Apr 27;17(1):24
pubmed: 27121374
BMC Med Ethics. 2019 Dec 27;20(1):103
pubmed: 31881966
BMC Fam Pract. 2019 Jun 15;20(1):83
pubmed: 31202259
J Oncol Pract. 2017 Oct;13(10):683-686
pubmed: 28850311
Scand J Public Health. 2009 May;37(3):260-4
pubmed: 19181822
BMC Med Ethics. 2018 May 30;19(1):40
pubmed: 29843682
Lakartidningen. 2020 Sep 07;117:
pubmed: 32894514